DR. BENJAMIN PAUL LOWRY M.D. NPI 1609024371

NPI Details

DR. Benjamin Paul Lowry, M.D. is an interventional pain medicine pain medicine in Temple, TX. The provider is interventional Pain Medicine is the discipline of medicine devoted to the diagnosis and treatment of pain and related disorders principally with the application of interventional techniques in managing subacute, chronic, persistent, and intractable pain, independently or in conjunction with other modalities of treatment. DR. Benjamin Paul Lowry, M.D. NPI is 1609024371. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

11435 FALCON DR
TEMPLE, TX
ZIP 76502-422
Phone: (254) 231-8000

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0482)
• Testing for presence of drug, by chemistry analyzers (HCPCS:80307)
• Injection of lower or sacral spine facet joint using imaging guidance, single level (HCPCS:64493)
• Injection of lower or sacral spine facet joint using imaging guidance, second level (HCPCS:64494)
• Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint (HCPCS:64636)
• Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint (HCPCS:64635)
• Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
• Testing for presence of drug, read by direct observation (HCPCS:80305)
• Injection of upper or middle spine facet joint using imaging guidance, single level (HCPCS:64490)
• Injection of upper or middle spine facet joint using imaging guidance, second level (HCPCS:64491)
• Insertion of spinal neurostimulator electrode array through skin (HCPCS:63650)
• Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint (HCPCS:64634)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint (HCPCS:64633)
• Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level (HCPCS:64483)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0483)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• Heat destruction of intraosseous basivertebral nerve in bones of spine in lower back, first two bones (HCPCS:64628)
• Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance (HCPCS:27096)
• Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose (HCPCS:J7321)
• Injection of lower or sacral spine facet joint using imaging guidance, single level (HCPCS:64493)
• Injection of lower or sacral spine facet joint using imaging guidance, second level (HCPCS:64494)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection of substance into middle or upper spine canal using imaging guidance (HCPCS:62321)
• Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level (HCPCS:64484)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0481)
• Injection of substance into lower spine canal using imaging guidance (HCPCS:62323)
• Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml (HCPCS:Q9966)
• Fusion of spine in lower back (HCPCS:22612)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Insertion of spinal neurostimulator generator or receiver (HCPCS:63685)
• Destruction of peripheral nerve or branch (HCPCS:64640)
• Injection of upper or middle spine facet joint using imaging guidance, single level (HCPCS:64490)
• Fluoroscopic guidance for needle placement (HCPCS:77002)
• Injection of upper or middle spine facet joint using imaging guidance, second level (HCPCS:64491)
• Fusion of pelvic joint using imaging guidance (HCPCS:27279)
• Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint (HCPCS:64636)
• Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint (HCPCS:64635)
• Partial removal of spine bone with release of lower spinal cord or nerves and/or removal of disc (HCPCS:63030)
• Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level (HCPCS:64483)

The enumeration date for this NPI number is 9/5/2008 and was last updated on 11/3/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.